Ischemic Optic Neuropathy

Monica Rodriguez Fontal; John B. Kerrison; Reinaldo Garcia; Veronica Oria

doi:10.1055/s-2007-979686

Seminars in Neurology, Inhaltsverzeichnis

Semin Neurol 2007; 27(3): 221-232
DOI: 10.1055/s-2007-979686

Ischemic Optic Neuropathy

Monica Rodriguez Fontal¹ , John B. Kerrison¹ , Reinaldo Garcia¹ , Veronica Oria¹

¹Retina and Neuro-Ophthalmology Division, Charleston Neuroscience Institute, Charleston, South Carolina

Abstract

ABSTRACT

Ischemic optic neuropathies (IONs) are the most frequent acute optic neuropathy in patients older than 50 years. They are classified according to the location of the ischemic damage into anterior ION and posterior ION. Ischemic optic neuropathies may also be categorized based on the presence or absence of temporal arteritis as an underlying etiology. Anterior ION presents with sudden, painless visual loss developing over hours to days. Examination findings usually include decreased visual acuity, a visual field defect, color vision loss, a relative afferent pupillary defect, and a swollen optic nerve head. Posterior ION occurs in arteritic, nonarteritic, and surgical settings. It is characterized by acute vision loss without initial disc edema but with subsequent optic disc atrophy.

KEYWORDS

Optic neuropathy - arteritic - nonarteritic

Volltext

Referenzen

REFERENCES

1 Rucker J C, Biousse V, Newman N J. Ischemic optic neuropathies. Curr Opin Neurol. 2004; 17 27-35
2 Onda E, Cioffi G A, Bacon D R, Van Buskirk E M. Microvasculature of the human optic nerve. Am J Ophthalmol. 1995; 120 92-102
3 Hayreh S S, Podhajsky P A, Zimmerman B. Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol. 1997; 123 285-296
4 Liu N H, LaBree L D, Feldon S E, Rao N A. The epidemiology of giant cell arteritis: a 12-year retrospective study. Ophthalmology. 2001; 108 1145-1149
5 Tomsak R L. Giant cell arteritis. Ophthalmology. 2002; 109 219-220
6 Hayreh S S, Zimmerman B. Management of giant cell arteritis-our 27-year clinical study: new light on old controversies. Ophthalmologica. 2003; 217 239-259
7 Guyer D R, Miller N R, Auer C L, Fine S L. The risk of cerebrovascular and cardiovascular disease in patients with anterior ischemic optic neuropathy. Arch Ophthalmol. 1985; 103 1136-1142
8 Henkind P, Charles N C, Pearson J. Histopathology of ischemic optic neuropathy. Am J Ophthalmol. 1970; 69 78-90
9 Rootman J, Butler D. Ischaemic optic neuropathy: a combined mechanism. Br J Ophthalmol. 1980; 64 826-831
10 Nordborg E, Nordborg C. Giant cell arteritis: epidemiology clues to its pathogenesis and an update on its treatment. Rheumatology. 2003; 42 413-421
11 Liu G T, Glaser J S, Schatz N J, Smith J L. Visual morbidity in giant cell arteritis. Ophthalmology. 1994; 101 1779-1785
12 Aiello P D, Trautmann J C, McPhee T J, Kunselman A R, Hunder G G. Visual prognosis in giant cell arteritis. Ophthalmology. 1993; 100 550-555
13 Repka M X, Savino P J, Schatz N J, Sergott R C. Clinical profile and long-term implications of anterior ischemic optic neuropathy. Am J Ophthalmol. 1983; 96 478-483
14 Hayreh S S, Podhajsky P A, Zimmerman B. Ocular manifestation of giant cell arteritis. Am J Ophthalmol. 1998; 125 509-520
15 Hayreh S S. Anterior ischemic optic neuropathy: differentiation of arteritic from nonarteritic type and its management. Eye. 1990; 4 25-41
16 Siatkowski R M, Gass J D, Glaser J S, Smith J L, Schatz N J, Schiffman J. Fluorescein angiography in the diagnosis of giant cell arteritis. Am J Ophthalmol. 1993; 115 57-63
17 Melberg N S, Grand M G, Dieckert P J. Cotton-wool spots and the early diagnosis of giant cell arteritis. Ophthalmology. 1995; 102 1611-1614
18 Arnold A C, Hepler R S. Fluorescein angiography in acute nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1994; 117 222-230
19 Arnold A C, Badr M A, Hepler R S. Fluorescein angiography in nonischemic optic disc edema. Arch Ophthalmol. 1996; 114 293-298
20 Mack H G, O'Day J, Currie J N. Delayed choroidal perfusion in giant cell arteritis. J Clin Neuroophthalmol. 1991; 11 221-227
21 Hayreh S S, Podhajsky P A, Raman R, Zimmerman B. Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol. 1997; 123 285-296
22 Jones J G, Hazleman B L. Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis. 1981; 40 1-5
23 Miller A, Green M, Robinson D. Simple rule for calculating normal erythrocyte sedimentation rate. Br Med J (Clin Res Ed). 1983; 286 266
24 Zweegman S, Makkink B, Stehouwer C D. Giant cell arteritis with normal erythrocyte sedimentation rate: case report and review of the literature. Neth J Med. 1993; 42 128-131
25 Small J M, Gavrilescu K. The serum protein changes in giant cell arteritis. J Neurol Neurosurg Psychiatry. 1963; 26 257-261
26 Eshaghian J, Goeken J A. C-reactive protein in giant cell (cranial, temporal) arteritis. Ophthalmology. 1980; 87 1160-1166
27 Krishna R, Kosmorsky G S. Implications of thrombocytosis in giant cell arteritis. Am J Ophthalmol. 1997; 124 103
28 Liozon E, Herrmann F, Ly K et al.. Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients. Am J Med. 2001; 111 211-217
29 Albert D M, Ruchman M C, Keltner J L. Skip lesion in temporal arteritis. Arch Ophthalmol. 1976; 94 2072-2077
30 McDonnell P J, Moore G W, Miller N R, Hutchins G M, Green W R. Temporal arteritis: a clinicopathologic study. Ophthalmology. 1986; 93 518-530
31 Hunder G G, Sheps S G, Allen G L, Joyce J W. Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis: comparison in a prospective study. Ann Intern Med. 1975; 82 613-618
32 Hedges 3rd T R, Gieger G L, Albert D M. The clinical value of negative temporal artery biopsy specimens. Arch Ophthalmol. 1983; 101 1251-1254
33 Guevara R A, Newman N J, Grossniklaus H E. Positive temporal artery biopsy 6 months after prednisone treatment. Arch Ophthalmol. 1998; 116 1252-1253
34 Chan C C, Paine M, O'Day J. Steroid management in giant cell arteritis. Br J Ophthalmol. 2001; 85 1061-1064
35 Hayreh S S, Zimmerman B, Kardon R H. Visual improvement with corticosteroid therapy in giant cell arteritis: report of a large study and review of the literature. Acta Ophthalmol Scand. 2002; 80 355-367
36 Foroozan R, Deramo V A, Buono L M et al.. Recovery of visual function in patients with biopsy-proven giant cell arteritis. Ophthalmology. 2003; 110 539-542
37 Beri M, Klugman M R, Kohler J A, Hayreh S S. Anterior ischemic optic neuropathy: VII. Incidence of bilaterality and various influencing factors. Ophthalmology. 1987; 94 1020-1028
38 Miller N R, Keltner J L, Gittinger J W. Giant cell (temporal) arteritis: the differential diagnosis. Surv Ophthalmol. 1979; 23 259-263
39 Hayreh S S, Zimmerman B. Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy. Ophthalmology. 2003; 110 1204-1215
40 Spiera R F, Mitnick H J, Kupersmith M. A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA). Clin Exp Rheumatol. 2001; 19 495-501
41 Jover J A, Hernandez Garcia C, Morado I C, Vargas E, Banares A, Fernandez-Gutierrez B. Combined treatment of giant-cell arteritis with methotrexate and prednisone: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2001; 134 106-114
42 Hoffman G S, Cid M C, Hellmann D B et al.. A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum. 2002; 46 1309-1318
43 Nesher G, Berkun Y, Mates M, Baras M, Rubinow A, Sonnenblick M. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum. 2004; 50 1332-1337
44 Weyand C M, Kaiser M, Yang H. Therapeutic effects of acetylsalicylic acid in giant cell arteritis. Arthritis Rheum. 2002; 46 457-466
45 Borruat F X, Herbort C P. Herpes zoster ophthalmicus: anterior ischemic optic neuropathy and acyclovir. J Clin Neuroophthalmol. 1992; 12 37-40
46 Isaak B L, Liesegang T J, Michet Jr C J. Ocular and systemic findings in relapsing polycondritis. Ophthalmology. 1986; 93 681-689
47 Crompton J L, Iyer P, Begg M W. Vasculitis and ischaemic optic neuropathy associated with rheumatoid arthritis. Aust J Ophthalmol. 1980; 8 219-230
48 Hsu C T, Kerrison J B, Miller N R, Goldberg M F. Choroidal infarction, anterior ischemic optic neuropathy, and central retinal artery occlusion from polyarteritis nodosa. Retina. 2001; 21 348-351
49 Kattah J C, Chrousos G A, Katz P A, McCasland B, Kolsky M P. Anterior ischemic optic neuropathy in Churg-Strauss syndrome. Neurology. 1994; 44 2200-2202
50 Ischemic Optic Neuropathy Decompression Trial Research Group . Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol. 1996; 114 1366-1374
51 Hattenhauer M G, Leavitt J A, Hodge D O, Grill R, Gray D T. Incidence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1997; 123 103-107
52 Boghen D R, Glaser J S. Ischaemic optic neuropathy: the clinical profile and history. Brain. 1975; 98 689-708
53 Hayreh S S, Joos K M, Podhajsky P A, Long C R. Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1994; 118 766-780
54 Chutorian A M, Winterkorn J M, Geffner M. Anterior ischemic optic neuropathy in children: case report and review of the literature. Pediatr Neurol. 2002; 26 358-364
55 Rizzo III J F, Lessell S. Optic neuritis and ischemic optic neuropathy: overlapping clinical profiles. Arch Ophthalmol. 1991; 109 1668-1672
56 Swartz N G, Beck R W, Savino P J et al.. Pain in anterior ischemic optic neuropathy. J Neuroophthalmol. 1995; 15 9-10
57 Cheng M A, Sigurdson W, Tempelhoff R, Lauryssen C. Visual loss after spine surgery: a survey. Neurosurgery. 2000; 46 625-630
58 Boone M I, Massry G G, Frankel R A, Holds J B, Chung S M. Visual outcome in bilateral nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 1996; 103 1223-1228
59 Olver J M, Spalton D J, McCartney A C. Microvascular study of the retrolaminar optic nerve in man: the possible significance in anterior ischaemic optic neuropathy. Eye. 1990; 4 7-24
60 Jonas J B, Gusek G C, Naumann G O. Anterior ischemic optic neuropathy: nonarteritic form in small and giant cell arteritis in normal sized optic discs. Int Ophthalmol. 1988; 12 119-125
61 Mansour A M, Shoch D, Logani S. Optic disk size in ischemic optic neuropathy. Am J Ophthalmol. 1988; 106 587-589
62 Feit R H, Tomsak R L, Ellenberger Jr C. Structural factors in the pathogenesis of ischemic optic neuropathy. Am J Ophthalmol. 1984; 98 105-108
63 Beck R W, Savino P J, Repka M X, Schatz N J, Sergott R C. Optic disc structure in anterior ischemic optic neuropathy. Ophthalmology. 1984; 91 1334-1337
64 Doro S, Lessell S. Cup-disc ratio and ischemic optic neuropathy. Arch Ophthalmol. 1985; 103 1143-1144
65 Burde R M. Optic disk risk factors for nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1993; 116 759-764
66 Hayreh S S, Zimmerman B. Visual field abnormalities in nonarteritic anterior ischemic optic neuropathy: their pattern and prevalence at initial examination. Arch Ophthalmol. 2005; 123 1554-1562
67 Arnold A C, Hepler R S. Natural history of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 1994; 14 66-69
68 Yee R D, Selky A K, Purvin V A. Outcomes of optic nerve sheath decompression for nonarteritic ischemic optic neuropathy. J Neuroophthalmol. 1994; 14 70-76
69 Sawle G V, James C B, Russell R W. The natural history of non-arteritic anterior ischaemic optic neuropathy. J Neurol Neurosurg Psychiatry. 1990; 53 830-833
70 Newman N J, Scherer R, Langenberg P et al.. Ischemic Optic Neuropathy Decompression Trial Research Group. The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol. 2002; 134 317-328
71 Cheng M A, Sigurdson W, Tempelhoff R, Lauryssen C. Visual loss after spine surgery: a survey. Neurosurgery. 2000; 46 625-630
72 Williams E L, Hart Jr W M, Tempelhoff R. Postoperative ischemic optic neuropathy. Anesth Analg. 1995; 80 1018-1029
73 Hayreh S S, Podhajsky P A, Zimmerman B. Ipsilateral recurrence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 2001; 132 734-742
74 Arnold A C. Pathogenesis of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 2003; 23 157-163
75 Hayreh S S, Zimmerman M B, Podhajsky P, Alward W L. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol. 1994; 117 603-624
76 Landau K, Winterkorn J M, Mailloux L U, Vetter W, Napolitano B. 24-hour blood pressure monitoring in patients with anterior ischemic optic neuropathy. Arch Ophthalmol. 1996; 114 570-575
77 Mojon D S, Hedges III T R, Ehrenberg B et al.. Association between sleep apnea syndrome and nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol. 2002; 120 601-605
78 Lee A G, Kohnen T, Ebner R et al.. Optic neuropathy associated with laser in situ keratomileusis. J Cataract Refract Surg. 2000; 26 1581-1584
79 Hayreh S S. Anterior ischemic optic neuropathy: IV. Occurrence after cataract extraction. Arch Ophthalmol. 1980; 98 1410-1416
80 Kim R, Van Stavern G, Juzych M. Nonarteritic anterior ischemic optic neuropathy associated with acute glaucoma secondary to Posner-Schlossman syndrome. Arch Ophthalmol. 2003; 121 127-128
81 Chiari M, Manzoni G C, Van de Geijn E J. Ischemic optic neuropathy after sumatriptan in a migraine with aura patient. Headache. 1994; 34 237-238
82 Egan R, Pomeranz H. Sildenafil (Viagra) associated anterior ischemic optic neuropathy. Arch Ophthalmol. 2000; 118 291-292
83 Hayreh S S. Erectile dysfunction drugs and non-arteritic anterior ischemic optic neuropathy: is there a cause and effect relationship?. J Neuroophthalmol. 2005; 25 295-298
84 Nagra P K, Foroozan R, Savino P J, Castillo I, Sergott R C. Amiodarone induced optic neuropathy. Br J Ophthalmol. 2003; 87 420-422
85 Fivgas G D, Newman N J. Anterior ischemic optic neuropathy following the use of a nasal decongestant. Am J Ophthalmol. 1999; 127 104-106
86 Kerrison J B. Optic neuropathies caused by toxins and adverse drug reactions. Ophthalmol Clin North Am. 2004; 17 481-488
87 Weger M, Stanger O, Deutschmann H et al.. Hyperhomocyst(e)inaemia, but not MTHFR C677T mutation, as a risk factor for non-arteritic ischaemic optic neuropathy. Br J Ophthalmol. 2001; 85 803-806
88 Kawasaki A, Purvin V A, Burgett R A. Hyperhomocysteinaemia in young patients with non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol. 1999; 83 1287-1290
89 Biousse V, Kerrison J B, Newman N J. Is non-arteritic anterior ischaemic optic neuropathy related to homocysteine?. Br J Ophthalmol. 2000; 84 555
90 Salomon O, Huna-Baron R, Kurtz S et al.. Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 1999; 106 739-742
91 Knox D L, Kerrison J B, Green W R. Histopathologic studies of ischemic optic neuropathy. Trans Am Ophthalmol Soc. 2000; 98 203-220
92 Sergott R C, Cohen M S, Bosley T M, Savino P J. Optic nerve decompression may improve the progressive form of nonarteritic ischemic optic neuropathy. Arch Ophthalmol. 1989; 107 1743-1754
93 Spoor T C, Wilkinson M J, Ramocki J M. Optic nerve sheath decompression for the treatment of progressive nonarteritic ischemic optic neuropathy. Am J Ophthalmol. 1991; 111 724-728
94 Kelman S E, Elman M J. Optic nerve sheath decompression for nonarteritic ischemic optic neuropathy improves multiple visual function measurements. Arch Ophthalmol. 1991; 109 667-671
95 The Ischemic Optic Neuropathy Decompression Trial Research Group . Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA. 1995; 273 625-632
96 Keltner J L, Becker B, Gay A J, Podos S M. Effect of diphenylhydantoin in ischemic optic neuritis. Trans Am Ophthalmol Soc. 1972; 70 113-130
97 Ellenberger Jr C, Burde R M, Keltner J L. Acute optic neuropathy: treatment with diphenylhydantoin. Arch Ophthalmol. 1974; 91 435-438
98 Kollarits C R, McCarthy R W, Corrie W S, Swann E R. Norepinephrine therapy of ischemic optic neuropathy. J Clin Neuroophthalmol. 1981; 1 283-288
99 Smith J L. Norepinephrine therapy of ischemic optic neuropathy. J Clin Neuroophthalmol. 1981; 1 289-290
100 Johnson L N, Guy M E, Krohel G B, Madsen R W. Levodopa may improve vision loss in recent-onset, nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2000; 107 521-526
101 Kupersmith M J, Frohman L, Sanderson M et al.. Aspirin reduces the incidence of second eye NAION: a retrospective study. J Neuroophthalmol. 1997; 17 250-253
102 Salomon O, Huna-Baron R, Steinberg D M, Kurtz S, Seligsohn U. Role of aspirin in reducing the frequency of second eye involvement in patients with non-arteritic anterior ischaemic optic neuropathy. Eye. 1999; 13 357-359
103 Beck R W, Hayreh S S, Podhajsky P A, Tan E S, Moke P S. Aspirin therapy in nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1997; 123 212-217
104 Soheilian M, Koochek A, Yazdani S, Peyman G A. Transvitreal optic neurotomy for nonarteritic anterior ischemic optic neuropathy. Retina. 2003; 23 692-697
105 Arnold A C, Levin L A. Treatment of ischemic optic neuropathy. Semin Ophthalmol. 2002; 17 39-46
106 Jonas J B, Spandau U H, Harder B, Sauder G. Intravitreal triamcinolone acetonide for treatment of acute nonarteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2006; May 4; , (Epub ahead of print)
107 Sadda S R, Nee M, Miller N R, Biousse V, Newman N J, Kouzis A. Clinical spectrum of posterior ischemic optic neuropathy. Am J Ophthalmol. 2001; 132 743-750
108 Hayreh S S. Posterior ischaemic optic neuropathy: clinical features, pathogenesis, and management. Eye. 2004; 18 1188-1206
109 Hayreh S S. Posterior ischemic optic neuropathy. Ophthalmologica. 1981; 182 29-41
110 Alexandrakis G, Lam B L. Bilateral posterior ischemic optic neuropathy after spinal surgery. Am J Ophthalmol. 1999; 127 354-355
111 Marks S C, Jaques D A, Hirata R M, Saunders Jr J R. Blindness following bilateral radical neck dissection. Head Neck. 1990; 12 342-345
112 Rizzo III J F, Lessell S. Posterior ischemic optic neuropathy during general surgery. Am J Ophthalmol. 1987; 103 808-811

John B KerrisonM.D.

Retina and Neuro-Ophthalmology Division, Charleston Neuroscience Institute

3531 Mary Ader Drive, Charleston, SC 29414-5741